Ablynx is a Belgian biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. The Company has proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, immuno-oncology, oncology and respiratory disease.

Employee Rating

2.8More
TypeSubsidiary
Parent CompanySanofi
HQGent, BE
Founded2001
Websiteablynx.com
Ablynx was founded in 2001 and is headquartered in Gent, BE
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Ablynx Office Locations

Ablynx has offices in Gent and Conshohocken
Gent, (HQ)
21 Technologiepark-Zwijnaarde
Conshohocken,
400 Eight Tower Bridge 161 Washington St
Show all (2)
Report incorrect company information

Ablynx Financials and Metrics

Summary Metrics

Founding Date

2001

Total Funding

$98.3 m
Ablynx is a subsidiary of Sanofi

Ablynx Revenue

Ablynx's revenue was reported to be €85.19 m in FY, 2016 which is a 9.9% increase from the previous period.
EURFY, 2015FY, 2016

Revenue

77.5m85.2m

Revenue growth, %

10%

General and administrative expense

11.4m13.5m

R&D expense

83.1m100.3m
Annual
EURFY, 2015FY, 2016

Cash

3.6m53.4m

Accounts Receivable

9.3m4.8m

Current Assets

246.1m242.2m

PP&E

2.6m3.7m
Quarterly
EURQ2, 2015Q2, 2016

Cash

53.4m26.4m

Accounts Receivable

4.8m4.1m

Current Assets

242.2m210.5m

PP&E

3.7m3.9m
Annual
EURFY, 2015FY, 2016

Net Income

(54.5m)(1.1m)

Depreciation and Amortization

1.1m1.8m

Accounts Payable

(45.2m)(43.2m)

Cash From Operating Activities

(69.0m)(66.6m)
Quarterly
EURQ2, 2016Q2, 2017

Net Income

22.8m(25.3m)

Depreciation and Amortization

885.0k1.5m

Accounts Payable

(21.4m)(7.9m)

Cash From Operating Activities

(17.2m)(29.3m)
Show all financial metrics

Ablynx Operating Metrics

Q2, 2017

Clinical Programs

45

Patents (US)

50

Patents (Foreign)

180

Patents and Patent Applications

400
Show all operating metrics
Report incorrect company information

Ablynx Online and Social Media Presence

Embed Graph
Report incorrect company information

Ablynx News and Updates

In- Depth Study in Blood-Brain Barrier Technologies Market Research 2018-2023, Key players - Allon Therapeutics, Inc., AngioChem Inc., Genzyme, CeNeRx BioPharma, Inc, Bioasis Technologies Inc., Ablynx NV, Capsulution Pharma AG and others

Global Blood-Brain Barrier Technologies market Revenue, Opportunity, Segment and Key Trends 2018-2023 Posted via Industry Today. Follow us on Twitter @IndustryToday

Nanobiotechnology Market 2018: Global Analysis by Key Players – Ablynx, CELGENE, Merck KGaA, Thermo Fisher Scientific

Wiseguyreports.Com Publish New Market Research Report On -“Nanobiotechnology Market - Global Industry Analysis, Size, Share, Trends, Growth and Forecast 2018 - 2022” Posted via Industry Today. Follow us on Twitter @IndustryToday

VC-backed Albynx debuts U.S. IPO

Ablynx, a Belgian biopharmaceutical company, has raised $200 million for its U.S. IPO after pricing its 11.4 million shares at $17.50 per share. The stock began trading October 25, 2017 on the NASDAQ under the ticker symbol “ABLX.” BofA Merrill Lynch, J.P. Morgan and Jefferies are the lead underwrit…

VC-backed Ablynx files for IPO

Ablynx, a Belgian biopharmaceutical company, has filed for an IPO. The number of shares that will be sold as well as the stock's pricing terms have yet to be set. Ablynx, which currently trades on the Euronext Brussels, is planning on listing its U.S. stock on the NASDAQ under the ticker symbol ABLX…
Report incorrect company information

Ablynx Company Life and Culture

Report incorrect company information

Ablynx Frequently Asked Questions

  • When was Ablynx founded?

    Ablynx was founded in 2001.

  • What is Ablynx revenue?

    Latest Ablynx annual revenue is €85.2 m.

  • Who are Ablynx competitors?

    Competitors of Ablynx include Kiniksa Pharmaceuticals, Sartorius Stedim BioOutsource and Neurosearch.

  • Where is Ablynx headquarters?

    Ablynx headquarters is located at 21 Technologiepark-Zwijnaarde, Gent.

  • Where are Ablynx offices?

    Ablynx has offices in Gent and Conshohocken.

  • How many offices does Ablynx have?

    Ablynx has 2 offices.